nervous system
• anesthetized mice exhibit episodic, low-frequency oscillations throughout the cerebral cortex ranging between 0.035 and 0.11 Hz, which can spontaneously develop very high power
• the high power state is associated with increased cortical neuron firing variability
• treatment with tetrodotoxin, a voltage-gated sodium channel blocker, decreases the low-frequency oscillations
• blocking L-type calcium channels with diltiazem reduces the high-state of the low-frequency oscillations
• blocking nitric oxide signaling with L-NAME results in an increase in high-power low-frequency oscillations in the cerebral cortex
• treatment with acetazolamide or 4-aminopyridine decreases the high-power low-frequency oscillations
|
• mice exhibit a reduced response of activity in the contralateral barrel cortex to air puffs delivered to the c2 whisker, indicating a deficit in processing of sensory inputs into the somatosensory cortex
|
• the ipsilateral and contralateral responses to intracortical stimulation are lower in mutants than in wild-type mice
• blocking ionotropic (with DNQX and APV) or metabotropic glutamate receptors (with LY36738 and MPEP) results in high-power low-frequency oscillations in mutants but not wild-type mice, indicating that the low-frequency oscillations in the cerebral cortex are facilitated by a reduction in excitatory synaptic transmission
|
• peak current densities of low voltage-activated (LVA) calcium channels in thalamocortical (TC) neurons at membrane potential of -50 mV are increased by 46% compared to control
• peak current densities of high voltage calcium channels (HVA) in TC neurons are increased compared to wild-type
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
episodic ataxia type 2 | DOID:0050990 |
OMIM:108500 |
J:221681 |